Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Emma Pailler"'
Autor:
Vincent Faugeroux, Emma Pailler, Marianne Oulhen, Olivier Deas, Laura Brulle-Soumare, Céline Hervieu, Virginie Marty, Kamelia Alexandrova, Kiki C. Andree, Nikolas H. Stoecklein, Dominique Tramalloni, Stefano Cairo, Maud NgoCamus, Claudio Nicotra, Leon W. M. M. Terstappen, Nicolo Manaresi, Valérie Lapierre, Karim Fizazi, Jean-Yves Scoazec, Yohann Loriot, Jean-Gabriel Judde, Françoise Farace
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-16 (2020)
Better tumor models are needed for the neuroendocrine subtype of castration resistant prostate cancer (CRPC-NE). Here, the authors develop patient-derived model from circulating tumor cells of a CRPC-NE patient, and provide insights on the sequential
Externí odkaz:
https://doaj.org/article/3ccca0e5b5dc46c78df201565348528a
Autor:
Rita Sulahian, Jason J. Kwon, Katherine H. Walsh, Emma Pailler, Timothy L. Bosse, Maneesha Thaker, Diego Almanza, Joshua M. Dempster, Joshua Pan, Federica Piccioni, Nancy Dumont, Alfredo Gonzalez, Jonathan Rennhack, Behnam Nabet, John A. Bachman, Amy Goodale, Yenarae Lee, Mukta Bagul, Rosy Liao, Adrija Navarro, Tina L. Yuan, Raymond W.S. Ng, Srivatsan Raghavan, Nathanael S. Gray, Aviad Tsherniak, Francisca Vazquez, David E. Root, Ari J. Firestone, Jeff Settleman, William C. Hahn, Andrew J. Aguirre
Publikováno v:
Cell Reports, Vol 29, Iss 1, Pp 118-134.e8 (2019)
Summary: The mitogen-activated protein kinase (MAPK) pathway is a critical effector of oncogenic RAS signaling, and MAPK pathway inhibition may be an effective combination treatment strategy. We performed genome-scale loss-of-function CRISPR-Cas9 scr
Externí odkaz:
https://doaj.org/article/9a62a78ea0ee4966a7135dceb3c889af
Autor:
Françoise Farace, Benjamin Besse, Jean-Charles Soria, David Planchard, Colin R. Lindsay, Frédéric Commo, Maud Ngo Camus, Fanny Billiot, Nathalie Auger, Kirsty Ross, Jordi Remon, Isabelle Borget, Marianne Oulhen, Emma Pailler
Supplementary data including: the legend for Supplementary Figure 1 the Supplementary Table 1 entitled detection of ALK-rearrangement and ALK copy number gain in tumors and CTC of ALK-rearranged patients the Supplementary Table 2 entitled descriptive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e0d42f1cde00594c6ab001a703c338b
https://doi.org/10.1158/0008-5472.22416362.v1
https://doi.org/10.1158/0008-5472.22416362.v1
Autor:
Françoise Farace, Benjamin Besse, Luc Friboulet, David Planchard, Ludovic Lacroix, Jordi Remon, Claudio Nicotra, Maud NgoCamus, Pauline Queffelec, Yann Lecluse, Aurélie Honoré, Mélanie Laporte, Laura Mezquita, Marianne Oulhen, Vincent Faugeroux, Emma Pailler
Supplementary Figure 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::760dc1718310c619a00eed160c4cbeac
https://doi.org/10.1158/1078-0432.22471109
https://doi.org/10.1158/1078-0432.22471109
Autor:
Françoise Farace, Benjamin Besse, Luc Friboulet, David Planchard, Ludovic Lacroix, Jordi Remon, Claudio Nicotra, Maud NgoCamus, Pauline Queffelec, Yann Lecluse, Aurélie Honoré, Mélanie Laporte, Laura Mezquita, Marianne Oulhen, Vincent Faugeroux, Emma Pailler
Supplementary Figure 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::733a2bf802b4eee904e3147642e8c1dc
https://doi.org/10.1158/1078-0432.22471115
https://doi.org/10.1158/1078-0432.22471115
Autor:
Françoise Farace, Benjamin Besse, Luc Friboulet, David Planchard, Ludovic Lacroix, Jordi Remon, Claudio Nicotra, Maud NgoCamus, Pauline Queffelec, Yann Lecluse, Aurélie Honoré, Mélanie Laporte, Laura Mezquita, Marianne Oulhen, Vincent Faugeroux, Emma Pailler
Supplementary Figure 5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bba0b65e06864e570c776bd723bc9f3
https://doi.org/10.1158/1078-0432.22471106
https://doi.org/10.1158/1078-0432.22471106
Autor:
Françoise Farace, Benjamin Besse, Luc Friboulet, David Planchard, Ludovic Lacroix, Jordi Remon, Claudio Nicotra, Maud NgoCamus, Pauline Queffelec, Yann Lecluse, Aurélie Honoré, Mélanie Laporte, Laura Mezquita, Marianne Oulhen, Vincent Faugeroux, Emma Pailler
Supplementary Table 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54f640d18e79af52e6c665a784618c8b
https://doi.org/10.1158/1078-0432.22471097
https://doi.org/10.1158/1078-0432.22471097
Autor:
Françoise Farace, Benjamin Besse, Luc Friboulet, David Planchard, Ludovic Lacroix, Jordi Remon, Claudio Nicotra, Maud NgoCamus, Pauline Queffelec, Yann Lecluse, Aurélie Honoré, Mélanie Laporte, Laura Mezquita, Marianne Oulhen, Vincent Faugeroux, Emma Pailler
Supplementary Figure 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::514aec5657e536164c0740459fdcc36f
https://doi.org/10.1158/1078-0432.22471118
https://doi.org/10.1158/1078-0432.22471118
Autor:
Françoise Farace, Benjamin Besse, Jean-Charles Soria, David Planchard, Colin R. Lindsay, Frédéric Commo, Maud Ngo Camus, Fanny Billiot, Nathalie Auger, Kirsty Ross, Jordi Remon, Isabelle Borget, Marianne Oulhen, Emma Pailler
The duration and magnitude of clinical response are unpredictable in ALK-rearranged non–small cell lung cancer (NSCLC) patients treated with crizotinib, although all patients invariably develop resistance. Here, we evaluated whether circulating tum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e28e8d51eff6016668c798561e839fb
https://doi.org/10.1158/0008-5472.c.6509534
https://doi.org/10.1158/0008-5472.c.6509534
Autor:
Françoise Farace, Benjamin Besse, Luc Friboulet, David Planchard, Ludovic Lacroix, Jordi Remon, Claudio Nicotra, Maud NgoCamus, Pauline Queffelec, Yann Lecluse, Aurélie Honoré, Mélanie Laporte, Laura Mezquita, Marianne Oulhen, Vincent Faugeroux, Emma Pailler
Supplementary Data - text
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::709a5f3fe574e3759dd09b92b02f6339
https://doi.org/10.1158/1078-0432.22471121.v1
https://doi.org/10.1158/1078-0432.22471121.v1